Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001468308-26-000012

CHIEF FINANCIAL OFFICER acquired 29,735 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Andrade Robert · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-18 Exercise or conversion : show line 1 in the form +2,450 $4.08 $9,996 215,108 D
2026-02-18 Exercise or conversion : show line 2 in the form +27,285 242,393 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-18 Exercise or conversion : show line 3 in the form Stock Options −2,450 $4.08 $9,996 814,117 D
Loading xslF345X05/form4-02192026_110240.xml…